|
RetrovirDrug - Retrovir The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Zidovudine
Strength -
200MG
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
020518
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 19, 1995
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Glaxosmithkline
Retrovir
Zidovudine 50mg/5ml Syrup; Oral
Retrovir 200mg Tablet; Oral Relenza 5mg Powder; Inhalation Prialt 100ugm/1ml(100mg/ml) Injectable; Intrathecal Prialt 200ugm/2ml (100mg/ml) Injectable; Intrathecal Prialt 500ugm/20ml(25mg/ml) Injectable; Intrathecal Prialt 500ugm/5ml(100mg/ml) Injectable; Intrathecal Retrovir 100mg Capsule; Oral Retrovir 10mg/ml Injectable; Injection Retrovir 50mg/5ml Syrup; Oral NewDrugInformation |